Loading...

Ultra-LEAF™ Purified anti-mouse CD28 Antibody

Pricing & Availability
Clone
37.51 (See other available formats)
Regulatory Status
RUO
Other Names
Tp44, T44
Isotype
Syrian Hamster IgG
Ave. Rating
Submit a Review
Product Citations
publications
37pt51_LEAF_081908
C57BL/6 splenocytes stained with LEAF™ purified 37.51, followed by anti-Syrian hamster IgG FITC
  • 37pt51_LEAF_081908
    C57BL/6 splenocytes stained with LEAF™ purified 37.51, followed by anti-Syrian hamster IgG FITC
Compare all formats
Cat # Size Price Quantity Check Availability Save
102122 25 mg 1127€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
102131 50 mg 1884€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
102132 100 mg 2707€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
102115 100 µg 88€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
102116 1 mg 132€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
102121 5 mg 432€
Check Availability


Need larger quantities of this item?
Request Bulk Quote

Select size of product is eligible for a 40% discount! Promotion valid until December 31, 2024. Exclusions apply. To view full promotion terms and conditions or to contact your local BioLegend representative to receive a quote, visit our webpage.

Description

CD28 is a 44 kD glycoprotein, also known as Tp44 or T44. It is a member of the Ig superfamily, expressed on thymocytes, most peripheral T cells, and NK cells. In association with CD80 (B7-1) and CD86 (B7-2), CD28 acts as the second signal for T and NK cell activation and proliferation. The 37.51 antibody has been reported to augment in vitro T cell proliferation and cytokine production, and promote CTL development.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Syrian Hamster
Immunogen
C57BL/6 mouse T-cell lymphoma EL-4
Formulation
0.2 µm filtered in phosphate-buffered solution, pH 7.2, containing no preservative.
Endotoxin Level
Less than 0.01 EU/µg of the protein (< 0.001 ng/µg of the protein) as determined by the LAL test.
Preparation
The Ultra-LEAF™ (Low Endotoxin, Azide-Free) antibody was purified by affinity chromatography.
Concentration
The antibody is bottled at the concentration indicated on the vial, typically between 2 mg/mL and 3 mg/mL. Older lots may have also been bottled at 1 mg/mL. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. This Ultra-LEAF™ solution contains no preservative; handle under aseptic conditions.
Application

FC - Quality tested
IP, IHC-F, Costim, Block - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 µg per million cells in 100 µl volume or 100 µl of whole blood. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats) include: immunoprecipitation1, in vitro costimulation of T and NK cells1, in vitro blocking of allogeneic mixed leukocyte response and inhibition of MHC-unrestricted CTL cytotoxicity3,4, in vitro induction of thymocyte differentiation2,5-9,11, and immunohistochemical staining of acetone-fixed frozen sections. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 102116).

Additional Product Notes

Get a 50% discount on this product when purchased in our Activation Bundles. Restrictions apply. Learn more…

Application References

(PubMed link indicates BioLegend citation)
  1. Gross JA, et al. 1992. J. Immunol. 149:380. (IP, Costim)
  2. Cibotti R, et al. 1997. Immunity 6:245. (Costim)
  3. Masten BJ, et al. 1997. Am. J. Respir. Cell Mol. Biol. 16:335. (Block)
  4. Nishio M, et al. 1996. J. Immunol. 157:4347. (Block)
  5. Zhang N and He Y-W, 2005. J. Exp. Med. 202:395. (Costim)
  6. Terrazas LI, et al. 2005. Intl. J. Parasitology. 35:1349. (Costim)
  7. Perchonock CE, et al. 2006. Mol Cell Biol. 26(16):6005. (Costim)
  8. Wang W, et al. 2007. J. Immunol. 178:4885. (Costim)
  9. Pua HH, et al. 2007. J. Exp. Med. 204:25. (Costim)
  10. Perchonock CE, et al. 2007. J. Immunol. 179:1768.
  11. Barbi J, et al. 2007. Blood 110:2215.
  12. Milpied P, et al. 2011. Blood 118:2993. PubMed
  13. Cunningham NR, et al. 2011. Int Immunol. 23:693. PubMed
  14. Crispin JC, et al. 2012. J. Immunol. 188:3567. PubMed
  15. Li CR, et al. 2014. J Immunol. 192:1425. PubMed
  16. Blankenhaus B, et al. 2014. PLoS Pathog. 10:1003913. PubMed
Product Citations
  1. Liu T, et al. 2023. Cardiovasc Res. 119:1046. PubMed
  2. Mirji G, et al. 2022. Sci Immunol. 7:eabn0704. PubMed
  3. Aso K, et al. 2023. Nat Commun. 14:984. PubMed
  4. Li X, et al. 2023. J Clin Invest. 133:. PubMed
  5. Mammadli M, et al. 2023. Int J Mol Sci. 24:. PubMed
  6. Mabire M, et al. 2023. Nat Commun. 14:1830. PubMed
  7. Xiao X, et al. 2023. Nat Commun. 14:2859. PubMed
  8. Vereertbrugghen A, et al. 2023. J Neuroinflammation. 20:120. PubMed
  9. Wang T, et al. 2023. Commun Biol. 6:613. PubMed
  10. Yao RQ, et al. 2023. Mil Med Res. 10:27. PubMed
  11. Mammadli M, et al. 2021. Clin Transl Med. 11:e625. PubMed
  12. Jairaman A, et al. 2021. Bio Protoc. 11:e4170. PubMed
  13. Li H, et al. 2022. Cancer Cell. 40:36. PubMed
  14. Kwon H, et al. 2022. Sci Immunol. 7:eabq2630. PubMed
  15. Chen C, et al. 2022. Sci Adv. 8:eabo4363. PubMed
  16. Krishnamurty AT, et al. 2022. Nature. 611:148. PubMed
  17. Klaus T, et al. 2022. JCI Insight. 7: . PubMed
  18. Zhang H, et al. 2022. J Clin Invest. 132: . PubMed
  19. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  20. Wang Z, et al. 2022. Cell Rep. 41:111890. PubMed
  21. Jiang YP, et al. 2022. Int J Mol Sci. 24: . PubMed
  22. Jiang X, et al. 2023. Cell Discov. 9:7. PubMed
  23. Pitmon E, et al. 2023. PLoS One. 18:e0280916. PubMed
  24. Hajjar S, et al. 2022. Cell Death Differ. 29:585. PubMed
  25. Ye L, et al. 2022. Cell Metab. 34:595. PubMed
  26. Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
  27. Denk D, et al. 2022. Immunity. 55:2059. PubMed
  28. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  29. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  30. Otano I, et al. 2021. Nat Commun. 12:7296. PubMed
  31. Jiang C, et al. 2020. Int J Biol Sci. 2.802083333. PubMed
  32. Gkountidi AO, et al. 2021. Cancer Immunol Res. 9:748. PubMed
  33. Zhao X, et al. 2021. Int J Oral Sci. 13:31. PubMed
  34. Bromley SK, et al. 2020. Cell Reports. 32(9):108085. PubMed
  35. Krone A, et al. 2022. Sci Rep. 218:. PubMed
  36. Menzel L, et al. 2021. Cell Rep. 37:109878. PubMed
  37. Saito S, et al. 2020. Nutrients. 12:. PubMed
  38. Byun JK, et al. 2020. Molecular Cell. 80(4):592-606.e8. PubMed
  39. Liu W, et al. 2021. Stem Cell Res Ther. 12:153. PubMed
  40. Potluri HK, et al. 2022. J Immunother Cancer. 10:. PubMed
  41. Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
  42. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  43. Zhang C, et al. 2020. Cell Metabolism. 31(1):148-161.e5.. PubMed
  44. Montes de Oca M, et al. 2020. PLoS Pathog. 16:e1008994. PubMed
  45. Hoover DB, et al. 2020. Int Immunopharmacol. 106359:81. PubMed
  46. Sekiya T et al. 2018. Cell reports. 24(6):1627-1638 . PubMed
  47. Pfenninger P, et al. 2022. Front Immunol. 13:777113. PubMed
  48. Stump CT, et al. 2021. Open Biol. 11:210245. PubMed
  49. Mammadli M, et al. 2021. Cancers (Basel). 13:. PubMed
  50. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  51. Cheng B, et al. 2022. Cancer Commun (Lond). 42:17. PubMed
  52. Gudgeon N, et al. 2022. Cell Rep. 40:111193. PubMed
  53. Yuan Y, et al. 2022. Cell Rep. 38:110256. PubMed
  54. Herrera FG, et al. 2021. Cancer Discov. Online ahead of print. PubMed
  55. James OJ, et al. 2021. Nat Commun. 12:4290. PubMed
  56. Garo LP, et al. 2019. Cell Rep. 28:3353. PubMed
  57. Saragovi A, et al. 2020. Elife. 9:00. PubMed
  58. Wu J et al. 2019. Immunity. 50(5):1218-1231 . PubMed
  59. Kanno T, et al. 2022. Front Immunol. 13:904875. PubMed
  60. Han K, et al. 2021. Nat Metab. 3:318. PubMed
  61. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  62. Peng L, et al. 2022. Cell Rep Med. 3:100634. PubMed
  63. Becker W, et al. 2021. J Crohns Colitis. 15:1032. PubMed
  64. Ohtsuka J, et al. 2021. iScience. Online ahead of print. PubMed
  65. Daneshmandi S, et al. 2021. Elife. 10:. PubMed
  66. Liu J, et al. 2020. Nat Commun. 11:6396. PubMed
  67. Watson MJ, et al. 2021. Nature. 591:645. PubMed
  68. Zhai X, et al. 2021. Sci Adv. 7:eabk0490. PubMed
  69. Zhang R, et al. 2022. Front Pharmacol. 13:870848. PubMed
  70. Ma X, et al. 2020. Immunity. 53:1315. PubMed
  71. Ye Q, et al. 2022. NPJ Vaccines. 7:84. PubMed
  72. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  73. He Y, et al. 2019. JCI Insight. 4:e130416. PubMed
  74. Yuan X, et al. 2017. Elife. 6:e29540. PubMed
  75. Minns D, et al. 2021. Nat Commun. 12:1285. PubMed
  76. Wang D, et al. 2022. EMBO Rep. 23:e53691. PubMed
  77. Daneshmandi S, et al. 2021. Cell Reports. 34(10):108831. PubMed
  78. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  79. Koch K, et al. 2022. Int J Mol Sci. 23:. PubMed
  80. Xu Y, et al. 2021. iScience. 24:103445. PubMed
  81. Sobecki M, et al. 2022. Cell Stem Cell. 29:1459. PubMed
  82. Kumar V, et al. 2022. JACC Basic Transl Sci. 7:1038. PubMed
  83. Xu L, et al. 2022. Nat Commun. 13:6881. PubMed
  84. Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed
  85. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  86. Kerdidani D, et al. 2022. J Exp Med. 219:. PubMed
  87. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  88. Okubo A, et al. 2021. Int J Mol Sci. 23:. PubMed
  89. Liu Y, et al. 2021. Nat Commun. 12:6831. PubMed
  90. Li X, et al. 2021. Front Cell Dev Biol. 9:647713. PubMed
RRID
AB_11147170 (BioLegend Cat. No. 102122)
AB_11147170 (BioLegend Cat. No. 102131)
AB_11147170 (BioLegend Cat. No. 102132)
AB_11147170 (BioLegend Cat. No. 102115)
AB_11147170 (BioLegend Cat. No. 102116)
AB_11147170 (BioLegend Cat. No. 102121)
Disclaimer

This product may be used for research purposes only. It is not licensed for resale and may only be used by the buyer. This product may not be used and is not licensed for clinical assays where the results of such assays are provided as a diagnostic service. If a diagnostic or therapeutic use is anticipated then a license must be requested from the University of California. The availability of such diagnostic and therapeutic use license(s) cannot be guaranteed from the University of California.

Antigen Details

Structure
Ig superfamily, 44 kD
Distribution

Thymocytes, CD4+, CD8+ peripheral T cells, NK cells

Function
Costimulates T and NK cells
Ligand/Receptor
CD80 (B7-1), CD86 (B7-2)
Cell Type
NK cells, T cells, Thymocytes, Tregs
Biology Area
Costimulatory Molecules, Immunology
Molecular Family
CD Molecules
Antigen References

1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Lenschow DJ, et al. 1996. Annu. Rev. Immunol. 14:233.
3. Gross JA, et al. 1992. J. Immunol. 149:380.

Gene ID
12487 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD28
Specificity Alt (DOES NOT SHOW ON TDS):
CD28
App Abbreviation (DOES NOT SHOW ON TDS):
FC,IP,IHC-F,Costim,Block
UniProt
View information about CD28 on UniProt.org

Related FAQs

Do you guarantee that your antibodies are totally pathogen free?

BioLegend does not test for pathogens in-house aside from the GoInVivo™ product line. However, upon request, this can be tested on a custom basis with an outside, independent laboratory.

Does BioLegend test each Ultra-LEAF™ antibody by functional assay?

No, BioLegend does not test Ultra-LEAF™ antibodies by functional assays unless otherwise indicated. Due to the possible complexities and variations of uses of biofunctional antibodies in different assays and because of the large product portfolio, BioLegend does not currently perform functional assays as a routine QC for the antibodies. However, we do provide references in which the antibodies were used for functional assays and we do perform QC to verify the specificity and quality of the antibody based on our strict specification criteria.

Does BioLegend test each Ultra-LEAF™ antibody for potential pathogens?

No, BioLegend does not test for pathogens in-house unless otherwise indicated.  However, we can recommend an outside vendor to perform this testing as needed.

Have you tested this Ultra-LEAF™ antibody for in vivo or in vitro applications?

We don't test our antibodies for in vivo or in vitro applications unless otherwise indicated. Depending on the product, the TDS may describe literature supporting usage of a particular product for bioassay. It may be best to further consult the literature to find clone specific information.

Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account